Profile
Gilbert M.
Rishton was the founder of Cognition Therapeutics, Inc., founded in 2007, where the title held was Chief Chemistry Advisor from 2007 to 2009.
Dr. Rishton is the founder of Channel Islands Alzheimer's Institute, founded in 2004, where the title held was Director from 2004 to 2010.
Dr. Rishton currently serves as Member-Scientific Advisory Board at Cardax, Inc. since 2008.
Former jobs include Chemistry Manager at Amgen, Inc. from 1995 to 2004 and Chief Science Officer at Cardax Pharmaceuticals, Inc. Education includes an undergraduate degree from the University of Rhode Island conferred in 1983 and a doctorate from Florida State University conferred in 1988.
Gilbert Rishton active positions
| Companies | Position | Start |
|---|---|---|
| CARDAX, INC. | Corporate Officer/Principal | - |
Former positions of Gilbert Rishton
| Companies | Position | End |
|---|---|---|
Channel Islands Alzheimer's Institute | Founder | 01/12/2010 |
| AMGEN INC. | Corporate Officer/Principal | - |
| COGNITION THERAPEUTICS, INC. | Founder | - |
Cardax Pharmaceuticals, Inc.
Cardax Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops proprietary small molecule therapies for large unmet medical needs | Chief Tech/Sci/R&D Officer | - |
Training of Gilbert Rishton
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Amgen, Inc.
Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
University of Rhode Island
University of Rhode Island Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Florida State University
Florida State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cardax Pharmaceuticals, Inc.
Cardax Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops proprietary small molecule therapies for large unmet medical needs | Health Technology |
Cognition Therapeutics, Inc.
Cognition Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage neuroscience company that develops drugs to help restore normal cellular damage responses in neurodegenerative and neuro-ophthalmic disorders | Health Technology |
Cardax, Inc.
Cardax, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceuticals & dietary supplements | Health Technology |
Channel Islands Alzheimer's Institute |
- Stock Market
- Insiders
- Gilbert Rishton
















